Institutional Ownership Northwest Biotherapeutics Inc (NWBO)
This table provides information about the institutional ownership of Northwest Biotherapeutics Inc (NWBO). We have compiled data on the 13 institutions that hold shares in the stock, with a total of 673,624 shares, which have been reported (via 13F filing form) to have a value of $195,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Moloney Securities Asset Management, LLC
|
Oct 30, 2024 Q3 2024 |
462,215
shares
|
$129,420
0.02% of portfolio
|
Q3 2024
Added 8.93%
|
|
|
Opus Capital Group, LLC
|
Oct 31, 2024 Q3 2024 |
60,150
shares
|
$16,842
0.0% of portfolio
|
Q4 2022
Added 9.07%
|
|
|
Williams Jones Wealth Management, Llc.
New York, NY |
Nov 14, 2024 Q3 2024 |
35,000
shares
|
$9,800
0.0% of portfolio
|
Q2 2024
Reduced 12.5%
|
|
|
Ethos Financial Group, LLC
King Of Prussia, PA |
Nov 07, 2024 Q3 2024 |
23,700
shares
|
$6,636
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Mai Capital Management
|
Nov 07, 2024 Q3 2024 |
20,000
shares
|
$5,600
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Lee Danner & Bass Inc
|
Oct 30, 2024 Q3 2024 |
20,000
shares
|
$5,600
0.0% of portfolio
|
Q3 2017
New holding
|
|
|
Alpha Mark Advisors, LLC
Ft. Wright, KY |
Oct 16, 2024 Q3 2024 |
14,007
shares
|
$3,921
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Gofen & Glossberg LLC
|
Jan 13, 2023 Q4 2022 |
12,740
shares
|
$3,567
0.0% of portfolio
|
Q4 2020
New holding
|
|
|
Advisors Management Group Inc
|
Oct 31, 2024 Q3 2024 |
10,270
shares
|
$2,875
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Klcm Advisors, Inc.
|
Nov 06, 2024 Q3 2024 |
10,000
shares
|
$2,800
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Bartlett & Co. LLC
|
Jan 08, 2024 Q4 2023 |
4,292
shares
|
$1,201
0.0% of portfolio
|
Q1 2022
New holding
|
|
|
Coston, Mc Isaac & Partners
Bar Harbor, ME |
Oct 22, 2024 Q3 2024 |
1,000
shares
|
$280
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Hantz Financial Services, Inc.
|
Nov 13, 2024 Q3 2024 |
250
shares
|
$70
0.0% of portfolio
|
Q2 2024
New holding
|